Tickers

1. Composite Trajectory Verdict

Given BBT's business as a bank holding company, the income statement and balance sheet carry roughly equal weight for assessing financial performance, as net interest margin, asset quality, and capital ratios are primary drivers of bank valuation.

Composite Trajectory: Insufficient Data

The 2025 results reflect the combined entity post-Transaction (merger with Berkshire Hills Bancorp), while 2024 and prior periods reflect only Legacy Brookline (the accounting acquirer). The filing explicitly states historical results are not comparable. With only one annual period of combined results and no quarterly combined-period data provided in the filings, there are insufficient comparable periods to assess a trajectory for the current company.

2. Red Flags

• Merger discontinuity: 2025 results include four months of combined operations; 2024 and prior periods are Legacy Brookline only, making year-over-year comparisons not meaningful (10-K 2025-12-31, MD&A Results of Operations).
• GAAP vs. non-GAAP earnings gap widened: GAAP net income $90.3M vs. operating earnings $142.3M in 2025 (10-K 2025-12-31, Non-GAAP Financial Measures), compared to $68.7M vs. $72.4M in 2024, driven by $57.5M merger/restructuring expense and $6.2M Day 1 CECL provision (10-K 2025-12-31, MD&A Non-Interest Expense and Provision for Credit Losses).
• Efficiency ratio deteriorated to 70.48% in 2025 from 68.09% in 2024 (10-K 2025-12-31, MD&A Non-Interest Expense).
• Criticized assets rose to $683.7M at 12/31/2025 from $252.7M at 12/31/2024 (10-K 2025-12-31, MD&A Asset Quality).
• Nonperforming assets increased to $116.7M (0.50% of assets) from $70.5M (0.59% of assets) (10-K 2025-12-31, MD&A Asset Quality).
• Loans 90+ days past due and accruing jumped to $37.8M from $0.8M (10-K 2025-12-31, MD&A Asset Quality).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Insufficient Data

Overall Assessment: The 2025 income statement reflects the combined company post-Transaction, while 2024 and 2023 reflect only Legacy Brookline. The filing states historical results are not comparable. GAAP net income rose to $90.3M in 2025 from $68.7M in 2024, net interest income increased to $503.1M from $329.6M, and net interest margin improved to 3.56% from 3.06% (10-K 2025-12-31, MD&A Results of Operations). However, non-interest expense surged to $389.7M from $241.9M, largely due to $57.5M in merger and restructuring costs (10-K 2025-12-31, MD&A Non-Interest Expense). Provision for credit losses increased to $41.4M from $21.6M (10-K 2025-12-31, MD&A Provision for Credit Losses). Without comparable prior periods for the combined entity, a trajectory cannot be determined.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Overall Assessment: The 2025 cash flow statement shows net cash provided by operating activities of $224.4M, up from $105.0M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Investing activities provided $2.30B in 2025 (including $1.08B net cash acquired in acquisition) versus $139.6M used in 2024. Financing activities used $1.03B in 2025 versus $445.3M provided in 2024. These swings are dominated by the Transaction and are not comparable to prior periods. No quarterly cash flow data for the combined entity is provided in the filings. Therefore, a cash generation trajectory cannot be assessed.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

Overall Assessment: Total assets grew to $23.2B at 12/31/2025 from $11.9B at 12/31/2024, primarily due to the Transaction (10-K 2025-12-31, MD&A Balance Sheet). Loans and leases increased to $18.0B from $9.8B, deposits to $19.5B from $8.9B, and borrowed funds decreased to $788.4M from $1.5B (10-K 2025-12-31, MD&A Balance Sheet). Capital ratios improved: CET1 10.95% vs 10.46%, tangible equity ratio 8.62% vs 8.27% (10-K 2025-12-31, MD&A Capital Strength). However, these changes reflect the merger, not organic growth. With only one combined balance sheet date, no trend can be established.

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet data for the combined entity (post-Transaction) for Q4 2025, Q1 2026, Q2 2026 are referenced in the 10-Q filings but not provided in the document text.
• Comparable annual periods for the combined entity (e.g., 2026 full year) are not yet available.
• Legacy Berkshire standalone historical financials are not included in the filings.
• Organic (non-merger) performance metrics for the combined entity cannot be isolated from the provided data.